Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two business segments: surgical products segment and brachytherapy seed segment. The Company's surgical products business manufactures, markets and sells disposable devices primarily utilized in certain surgical procedures. The Company's brachytherapy seed business manufactures, markets and sells radioactive seeds primarily utilized in the treatment of early stage prostate cancer. The Company designs , manufactures, assembles, packages and distributes its surgical products in three primary production facilities, each of which manufactures different products. In October 2013, the Company announced that it has completed the merger with Juniper Acquisition Corporation.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
Phone+1-770-8315137
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Theragenics (NYSE:TGX) Frequently Asked Questions
What is Theragenics' stock symbol?
Theragenics trades on the New York Stock Exchange (NYSE) under the ticker symbol "TGX."
Has Theragenics been receiving favorable news coverage?
News stories about TGX stock have been trending somewhat positive recently, InfoTrie reports. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Theragenics earned a news impact score of 1.7 on InfoTrie's scale. They also assigned news articles about the medical device company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the near future.
How do I buy shares of Theragenics?
Shares of TGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Theragenics' stock price today?
One share of TGX stock can currently be purchased for approximately $0.12.
What is Theragenics' official website?
How can I contact Theragenics?
Theragenics' mailing address is 5203 Bristol Industrial Way, BUFORD, GA 30518, United States. The medical device company can be reached via phone at +1-770-8315137.
MarketBeat Community Rating for Theragenics (NYSE TGX)
MarketBeat's community ratings are surveys of what our community members think about Theragenics and other stocks. Vote "Outperform" if you believe TGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TGX will underperform the S&P 500 over the long term. You may vote once every thirty days.
